Baystate Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $4.83K | Hold |
147
| – | – | ﹤0.01% | 896 |
|
|
2023
Q3 | $4.1K | Hold |
147
| – | – | ﹤0.01% | 704 |
|
|
2023
Q2 | $5.02K | Hold |
147
| – | – | ﹤0.01% | 702 |
|
|
2023
Q1 | $4.43K | Buy |
147
+100
| +213% | +$3.01K | ﹤0.01% | 709 |
|
|
2022
Q4 | $1K | Hold |
47
| – | – | ﹤0.01% | 830 |
|
|
2022
Q3 | $2K | Hold |
47
| – | – | ﹤0.01% | 729 |
|
|
2022
Q2 | $1K | Hold |
47
| – | – | ﹤0.01% | 809 |
|
|
2022
Q1 | $2K | Sell |
47
-385
| -89% | -$16.4K | ﹤0.01% | 738 |
|
|
2021
Q4 | $26K | Hold |
432
| – | – | ﹤0.01% | 424 |
|
|
2021
Q3 | $32K | Buy |
432
+57
| +15% | +$4.22K | ﹤0.01% | 345 |
|
|
2021
Q2 | $35K | Hold |
375
| – | – | ﹤0.01% | 316 |
|
|
2021
Q1 | $33K | Buy |
375
+60
| +19% | +$5.28K | ﹤0.01% | 302 |
|
|
2020
Q4 | $29K | Buy |
+315
| New | +$29K | ﹤0.01% | 307 |
|
|
2020
Q3 | – | Sell |
-185
| Closed | -$10K | – | 640 |
|
|
2020
Q2 | $10K | Buy |
+185
| New | +$10K | ﹤0.01% | 385 |
|